Publicaciones en colaboración con investigadores/as de Hospital Ramón y Cajal (471)

2024

  1. A long-term survey of Serratia spp. bloodstream infections revealed an increase of antimicrobial resistance involving adult population

    Microbiology Spectrum, Vol. 12, Núm. 2

  2. Accurate and rapid antibiotic susceptibility testing using a machine learning-assisted nanomotion technology platform

    Nature Communications, Vol. 15, Núm. 1

  3. Activity of cefepime, carbapenems and new β-lactam/β-lactamase inhibitor combinations on Enterobacter cloacae complex and Klebsiella aerogenes in Spain (SMART 2016-2022)

    JAC-Antimicrobial Resistance, Vol. 6, Núm. 3

  4. Attributable mortality of infections caused by carbapenem-resistant Enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA)

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, Vol. 30, Núm. 2, pp. 223-230

  5. Bronchopulmonary colonization patterns in Spanish people with cystic fibrosis: Results of a national multicentre study

    Enfermedades Infecciosas y Microbiologia Clinica

  6. Corrigendum to “Propensity-Score Analysis Reveals that Sex is Not a Prognostic Factor for Mortality in Intensive Care Unit-Admitted Patients with Septic Bacteremia” [International Journal of Infectious Diseases, volume 110 (2021) pages 36-44, (S1201971221005907), (10.1016/j.ijid.2021.07.034)]

    International Journal of Infectious Diseases

  7. Epidemiological and clinical characterization of community, healthcare-associated and nosocomial colonization and infection due to carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Spain

    Infection

  8. Evolution of ceftazidime-avibactam and cefiderocol resistance in ST131-H30R1-Escherichia coli isolates with KPC-3 mutants and application of FTIR biotyping

    Microbiology Spectrum, Vol. 12, Núm. 4

  9. Factors Associated with SARS-CoV-2 Infection in Fully Vaccinated Nursing Home Residents and Workers

    Viruses, Vol. 16, Núm. 2

  10. In vitro activity of cefiderocol and other newly approved antimicrobials against multi-drug resistant Gram-negative pathogens recovered in intensive care units in Spain and Portugal

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 37, Núm. 1, pp. 69-77

  11. In vitro activity of cefiderocol in Pseudomonas aeruginosa isolates from people with cystic fibrosis recovered during three multicentre studies in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 79, Núm. 6, pp. 1432-1440

  12. In vitro activity of cefiderocolagainst European Enterobacterales, including isolates resistant to meropenem and recentβ-lactam/β-lactamase inhibitor combinations

    Microbiology Spectrum, Vol. 12, Núm. 8

  13. In vitro activity of ozenoxacin against Staphylococcus aureus and Streptococcus pyogenes clinical isolates recovered in a worldwide multicentre study (2020-2022)

    JAC-Antimicrobial Resistance, Vol. 6, Núm. 3

  14. International and regional spread of carbapenem-resistant Klebsiella pneumoniae in Europe

    Nature Communications, Vol. 15, Núm. 1

  15. Invasive pneumococcal disease in a tertiary hospital in Madrid: are we using pneumococcal vaccine correctly?

    Enfermedades Infecciosas y Microbiologia Clinica

  16. Monitoring of Pseudomonas aeruginosa mutational resistome dynamics using an enrichment panel for direct sequencing of clinical samples

    eBioMedicine, Vol. 108

  17. Risk factors and clinical impact of multidrug resistance in healthcare-associated bacteraemic urinary tract infections: a post-hoc analysis of a multicentre prospective cohort in Spain

    Journal of Hospital Infection, Vol. 151, pp. 173-185

  18. Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study

    Journal of Antimicrobial Chemotherapy, Vol. 79, Núm. 9, pp. 2132-2141

  19. The ICU environment contributes to the endemicity of the "Serratia marcescens complex" in the hospital setting

    mBio, Vol. 15, Núm. 5, pp. e0305423

  20. β-lactamase expression induces collateral sensitivity in Escherichia coli

    Nature communications, Vol. 15, Núm. 1, pp. 4731